KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 126 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $554,016 | -31.3% | 31,895 | -44.3% | 0.07% | -54.2% |
Q2 2023 | $806,418 | +156.3% | 57,274 | +95.9% | 0.14% | +144.1% |
Q1 2023 | $314,644 | -67.9% | 29,242 | -55.4% | 0.06% | -74.9% |
Q4 2022 | $981,639 | +42.1% | 65,530 | +21.7% | 0.24% | +49.7% |
Q3 2022 | $691,000 | – | 53,844 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 1,025,000 | $12,064,000 | 2.56% |
GREAT POINT PARTNERS LLC | 536,738 | $6,317,000 | 1.40% |
Endurant Capital Management LP | 244,125 | $2,873,000 | 0.69% |
HHLR ADVISORS, LTD. | 2,920,023 | $34,369,000 | 0.53% |
Integral Health Asset Management, LLC | 140,000 | $1,648,000 | 0.46% |
Spearhead Capital Advisors, LLC | 235,024 | $2,766,000 | 0.33% |
Jackson Creek Investment Advisors LLC | 77,069 | $907,000 | 0.32% |
RICE HALL JAMES & ASSOCIATES, LLC | 712,807 | $8,390,000 | 0.30% |
Parkman Healthcare Partners LLC | 113,644 | $1,338,000 | 0.30% |
Birchview Capital, LP | 30,000 | $353,000 | 0.23% |